Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
2 Assignments
0 Petitions
Accused Products
Abstract
The invention is directed to compounds of formula I:
- wherein R1, R2, R3, R4, R5, R6, R7a, R7b, W, G1, G2, a, b, c, d and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
-
Citations
67 Claims
-
1-15. -15. (canceled)
- 16. The compound of formula I:
- 17. The compound of formula I:
-
19-38. -38. (canceled)
Specification